packageNecitumumab

necitumumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Necitumumab is an EGFR-inhibiting monoclonal antibody used as an anticancer drug, notably for non-small-cell lung carcinoma. It is approved in some countries, mainly the United States, but its European Union marketing authorisation has been withdrawn, so it is not available there.

Summary written by glm-5.3-flash from Wikidata Q6985503 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:necitumumab
ATC codes:L01FE03
DrugBank:DB09559
Wikidata:Q6985503

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown